Press Releases | Alexion Pharmaceuticals, Inc

About Alexion
Patient Focus
Products
Research & Development
Responsibility
Careers
Select a Country
- North America
  - Canada
  - USA
- Latin America
  - Argentina
  - Brazil
  - Colombia
  - Mexico
- Europe, the Middle East & Africa
  - Alexion Europe
  - Belgium
  - Denmark
  - France
  - Germany
  - Ireland
  - Italy
  - Netherlands
  - Norway
  - Russia
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - UAE
  - UK
- Asia Pacific
  - Australia
  - China
  - India
  - Japan
Investors
News
Contact

Home
»
Newsroom
»
Press Releases

Press Releases

All News Releases

Alexion to Present at the 20th Annual Piper Jaffray Health Care Conference
November 25, 2008
HTML PDF
David W. Keiser to Retire as President of Alexion
November 11, 2008
HTML PDF
Researchers to Present Additional Data on Soliris® (eculizumab) for the Treatment of PNH at the ASH Annual Meeting
November 10, 2008
HTML PDF
Alexion to Present at Investor Conferences
November 4, 2008
HTML PDF
Alexion Reports Third Quarter 2008 Results
October 23, 2008
HTML PDF
Alexion Pharmaceuticals Invites You to Participate in its Third Quarter 2008 Results Conference Call and Web Cast
October 8, 2008
HTML PDF
Alexion's Soliris® Receives 2008 Prix Galien USA Award for Best Biotechnology Product
September 25, 2008
HTML PDF
Alexion to Present at the Morgan Stanley Global Healthcare Unplugged Conference
September 2, 2008
HTML PDF
Alexion Secures U.S. Patent for ALXN6000, a First-In-Class Anti-CD200 Monoclonal Antibody
August 7, 2008
HTML PDF
Alexion Reports Second Quarter 2008 Results
July 29, 2008
HTML PDF